Absci and AMD Announce Collaboration and Strategic Investment …
4 days ago · With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland.
Absci and AMD Announce Collaboration and Strategic Investment …
3 days ago · $20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm SoftwareVANCOUVER, Wash ...
Absci and Invetx Partner to Bring Generative AI Drug Creation …
6 days ago · VANCOUVER, Wash. and BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Invetx, a pioneer in protein-based therapeutics for animal health, today announced a strategic partnership to harness Absci’s AI Drug Creation models to create an innovative Half-Life Extension ...
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug …
3 days ago · AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices ...
Absci Highlights Progress and Updates Across Proprietary Pipeline …
Dec 12, 2024 · Drug candidate selected for ABS-201, a novel, potentially category-defining anti-PRLR antibody in development for androgenic alopecia. Leading AI platform demonstrated breakthrough in successful de novo design of antibody targeting previously difficult-to-drug epitope in the HIV “caldera” region.
Absci Announces Collaboration with AstraZeneca to Advance AI …
Dec 4, 2023 · Absci will contribute its pioneering generative AI technology to deliver a therapeutic candidate antibody for a specified oncology target. The agreement includes an upfront commitment, R&D funding and milestone payments, in addition to royalties on product sales.
Almirall and Absci announce AI drug discovery partnership to …
Nov 14, 2023 · The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation.
Absci and Invetx Partner to Bring Generative AI Drug Creation …
5 days ago · VANCOUVER, Wash. and BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Invetx, a pioneer in protein-based ...
Absci Corporation Announces Strategic Collaboration with AMD
3 days ago · Absci partners with AMD, investing $20 million to enhance AI-driven drug discovery and antibody design capabilities. Quiver AI Summary. Absci Corporation has announced a strategic partnership with ...
Absci Corporation and Owkin Announce Strategic Partnership for AI ...
1 day ago · Absci, known for its generative AI in drug creation, will work with Owkin's predictive AI technology to co-develop therapeutic candidates targeting areas like immuno-oncology and immunology.